China · Delayed Price · Currency is CNY Chemclin Diagnostics Statistics
Total Valuation
SHA:688468 has a market cap or net worth of CNY 2.86 billion. The enterprise value is 2.68 billion.
| Market Cap | 2.86B |
| Enterprise Value | 2.68B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
SHA:688468 has 394.59 million shares outstanding. The number of shares has increased by 0.53% in one year.
| Current Share Class | 394.59M |
| Shares Outstanding | 394.59M |
| Shares Change (YoY) | +0.53% |
| Shares Change (QoQ) | -19.65% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 16.06% |
| Float | 228.11M |
Valuation Ratios
The trailing PE ratio is 65.82.
| PE Ratio | 65.82 |
| Forward PE | n/a |
| PS Ratio | 8.59 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | 118.98 |
| P/OCF Ratio | 30.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.71, with an EV/FCF ratio of 111.68.
| EV / Earnings | 61.07 |
| EV / Sales | 8.06 |
| EV / EBITDA | 25.71 |
| EV / EBIT | 57.61 |
| EV / FCF | 111.68 |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.16.
| Current Ratio | 4.77 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | 9.66 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.11% and return on invested capital (ROIC) is 4.06%.
| Return on Equity (ROE) | 3.11% |
| Return on Assets (ROA) | 1.62% |
| Return on Invested Capital (ROIC) | 4.06% |
| Return on Capital Employed (ROCE) | 2.91% |
| Weighted Average Cost of Capital (WACC) | 4.58% |
| Revenue Per Employee | 528,901 |
| Profits Per Employee | 69,813 |
| Employee Count | 606 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.02 |
Taxes
In the past 12 months, SHA:688468 has paid 5.91 million in taxes.
| Income Tax | 5.91M |
| Effective Tax Rate | 11.86% |
Stock Price Statistics
The stock price has increased by +2.84% in the last 52 weeks. The beta is 0.13, so SHA:688468's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +2.84% |
| 50-Day Moving Average | 7.43 |
| 200-Day Moving Average | 7.81 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 2,907,887 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688468 had revenue of CNY 332.68 million and earned 43.91 million in profits. Earnings per share was 0.11.
| Revenue | 332.68M |
| Gross Profit | 221.16M |
| Operating Income | 46.55M |
| Pretax Income | 49.82M |
| Net Income | 43.91M |
| EBITDA | 93.49M |
| EBIT | 46.55M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 407.14 million in cash and 231.97 million in debt, with a net cash position of 175.18 million or 0.44 per share.
| Cash & Cash Equivalents | 407.14M |
| Total Debt | 231.97M |
| Net Cash | 175.18M |
| Net Cash Per Share | 0.44 |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 4.03 |
| Working Capital | 602.05M |
Cash Flow
In the last 12 months, operating cash flow was 93.90 million and capital expenditures -69.88 million, giving a free cash flow of 24.01 million.
| Operating Cash Flow | 93.90M |
| Capital Expenditures | -69.88M |
| Depreciation & Amortization | 46.94M |
| Net Borrowing | -20.00M |
| Free Cash Flow | 24.01M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 66.48%, with operating and profit margins of 13.99% and 13.20%.
| Gross Margin | 66.48% |
| Operating Margin | 13.99% |
| Pretax Margin | 14.97% |
| Profit Margin | 13.20% |
| EBITDA Margin | 28.10% |
| EBIT Margin | 13.99% |
| FCF Margin | 7.22% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.71%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.71% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 124.76% |
| Buyback Yield | -0.53% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 1.54% |
| FCF Yield | 0.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |